PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-3539

  1. 1,063 Posts.
    lightbulb Created with Sketch. 532
    One thing i would like to see is a cross-partner investment both ways between us and Bene.
    If PR wants institutional investors on board for a CR that is one way of earning his proposed remuneration benefits proposal that i could support.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.